Signal active
Contact Information
Social
Primary Organization
1887
882
640
89
10001+
Biotechnology, Health Care, Medical, Medical Device, Health Diagnostics
Bio
Dr. Broder brings more than 30 years of internal medicine and oncology experience to Intrexon. Most notably, Dr. Broder was Director of the National Cancer Institute (NCI) during the Reagan administration, a position he held for six years.
Before joining Intrexon in 2012, Dr. Broder was the Executive Vice President for Medical Affairs and Chief Medical Officer at Celera Corporation, now a division of Quest Diagnostics, where he helped advance the human genome project. While directing NCI, he oversaw the development of many anti-cancer therapeutic agents, helped launch a number of large-scale clinical trials related to the prevention, diagnosis and treatment of cancer, and launched the highly successful SPORE Program.
Dr. Broder also played a major role in developing the first three FDA-approved AIDS treatments. He has served as a board member and as a consultant for numerous pharmaceutical and biotech companies in the U.S. and abroad. Dr. Broder has authored or co-authored more than 340 scientific publications, holds multiple patents, and was elected to the Institute of Medicine of the National Academy of Sciences in 1993. Dr. Broder earned his M.D. from the University of Michigan Medical School in Ann Arbor in 1970.
Location
Germantown, Maryland, United States, North America
Jobs history
0
N/A
Educations
1
N/A
Profile Resume
Samuel Broder is the Director at National Institutes of Health, based in United States, North America. With a background in Biotechnology, Samuel Broder has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.